FOB Price
Get Latest Price|
- Minimum Order
Country:
China
Model No:
99.5%
FOB Price:
Place of Origin:
-
Price for Minimum Order:
-
Minimum Order Quantity:
-
Packaging Detail:
-
Delivery Time:
-
Supplying Ability:
-
Payment Type:
T/T
Product Group :
China
Contact Person John
Huizhan Road, Ningbo, Zhejiang
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It
was discovered in a U.S. National Cancer Institute program at the
Research Triangle Institute in ***7 when Monroe E. Wall and
Mansukh C. Wani isolated it from the bark of the Pacific yew
tree, Taxus brevifolia and named it taxol. When it was developed
commercially by Bristol-Myers Squibb (BMS) the generic name was
changed to paclitaxel and the BMS compound is sold under the
trademark TAXOL. In this formulation, paclitaxel is dissolved in
Cremophor EL and ethanol, as a delivery agent. A newer
formulation, in which paclitaxel is bound to albumin, is sold
under the trademark Abraxane.
Paclitaxel is now used to treat patients with lung, ovarian,
breast cancer, head and neck cancer, and advanced forms of
Kaposi's sarcoma. Paclitaxel is also used for the prevention of
restenosis.
| Country: | China |
| Model No: | 99.5% |
| FOB Price: | Get Latest Price |
| Place of Origin: | - |
| Price for Minimum Order: | - |
| Minimum Order Quantity: | - |
| Packaging Detail: | - |
| Delivery Time: | - |
| Supplying Ability: | - |
| Payment Type: | T/T |
| Product Group : | API |
